Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription

Articles published in Cancer Imaging

Retrieve available abstracts of 7 articles:
HTML format
Text format

Single Articles

    May 2018
  1. DAMJANOVIC J, Janssen JC, Furth C, Diederichs G, et al
    (68) Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer.
    Cancer Imaging. 2018;18:20.
    PubMed     Text format     Abstract available

    December 2017
  2. IRAVANI A, Hofman MS, Mulcahy T, Williams S, et al
    (68)Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer.
    Cancer Imaging. 2017;17:31.
    PubMed     Text format     Abstract available

  3. WILL L, Giesel FL, Freitag MT, Berger AK, et al
    Integration of CT urography improves diagnostic confidence of (68)Ga-PSMA-11 PET/CT in prostate cancer patients.
    Cancer Imaging. 2017;17:30.
    PubMed     Text format     Abstract available

    December 2016
  4. COUNAGO F, Recio M, Maldonado A, Del Cerro E, et al
    Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
    Cancer Imaging. 2016;16:42.
    PubMed     Text format     Abstract available

  5. BEAUREGARD JM, Beaulieu A
    How we read FCH-PET/CT for prostate cancer.
    Cancer Imaging. 2016;16:41.
    PubMed     Text format     Abstract available

    January 2016
  6. RAUSCHER I, Maurer T, Fendler WP, Sommer WH, et al
    (68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report.
    Cancer Imaging. 2016;16:14.
    PubMed     Text format     Abstract available

  7. SOLLINI M, Pasqualetti F, Perri M, Coraggio G, et al
    Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
    Cancer Imaging. 2016;16:27.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.